OXER1 mediates testosterone-induced calcium responses in prostate cancer cells

Mol Cell Endocrinol. 2022 Jan 1:539:111487. doi: 10.1016/j.mce.2021.111487. Epub 2021 Oct 8.

Abstract

In prostate cancer, calcium homeostasis plays a significant role in the disease's development and progression. Intracellular calcium changes are an important secondary signal, triggered by a variety of extracellular stimuli, that controls many cellular functions. One of the main events affecting calcium is androgen signaling. Indeed, via calcium changes, androgens regulate cell processes like cell growth, differentiation and motility. In the present work we explored the nature of the receptor involved in calcium response induced by membrane-acting testosterone in prostate cancer cells. We report that testosterone, independently of the presence of the classical androgen receptor, can rapidly increase intracellular calcium from calcium stores, through the oxoeicosanoid receptor 1 (OXER1) and a specific signaling cascade that triggers calcium release from the endoplasmic reticulum. These findings reveal for the first time the receptor involved in the rapid calcium changes induced by androgens. Moreover, they further support the notion that androgens, even in the absence of AR, can still exert specific effects that regulate cancer cell fate.

Keywords: Androgens; Calcium; GPCR; OXER1; Signaling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arachidonic Acids / pharmacology
  • Calcium / metabolism*
  • Calcium Signaling / drug effects
  • Cell Line, Tumor
  • Endoplasmic Reticulum / metabolism
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Male
  • Prostatic Neoplasms / metabolism*
  • Receptors, Eicosanoid / metabolism*
  • Testosterone / pharmacology*

Substances

  • 5-oxo-eicosatetraenoic acid
  • Arachidonic Acids
  • OXER1 protein, human
  • Receptors, Eicosanoid
  • Testosterone
  • Calcium